216 related articles for article (PubMed ID: 34776974)
1. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV)
Ge FL; Si LL; Yang Y; Li YH; Lv ZL; Liu WH; Liao H; Wang J; Zou J; Li L; Li H; Zhang ZL; Wang JB; Lu XC; Xu DP; Bai ZF; Liu Y; Xiao XH
Front Pharmacol; 2021; 12():756975. PubMed ID: 34776974
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatitis B virus
Ge FL; Yang Y; Si LL; Li YH; Cao MZ; Wang J; Bai ZF; Ren ZG; Xiao XH; Liu Y
World J Gastroenterol; 2024 Apr; 30(13):1911-1925. PubMed ID: 38659485
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
4. The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages.
Wu Z; Zhao X; Li R; Wen X; Xiu Y; Long M; Li J; Huang X; Wen J; Dong X; Xu Y; Bai Z; Zhan X; Xiao X
Chin Med; 2024 Mar; 19(1):48. PubMed ID: 38500179
[TBL] [Abstract][Full Text] [Related]
5. Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
Chen Y; Song Z; Hou X; Liu J; Zheng C; Zhao X; Lv G; Li J; Xiu Y; Shi W; Zhao J; Yang H; Wang Y; Zhao J; Zhan X; Niu M; Zou W; Bai Z; Xiao X
J Ethnopharmacol; 2024 Mar; 321():117406. PubMed ID: 37952733
[TBL] [Abstract][Full Text] [Related]
6. T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.
Sang X; Wang R; Han Y; Zhang C; Shen H; Yang Z; Xiong Y; Liu H; Liu S; Li R; Yang R; Wang J; Wang X; Bai Z; Xiao X
Acta Pharm Sin B; 2017 May; 7(3):311-318. PubMed ID: 28540167
[TBL] [Abstract][Full Text] [Related]
7. Total saponins extracted from Abrus cantoniensis Hance suppress hepatitis B virus replication in vitro and in rAAV8-1.3HBV transfected mice.
Yao X; Li Z; Gong X; Fu X; Xiao X; He M; Huang B; Xu Z
J Ethnopharmacol; 2020 Mar; 249():112366. PubMed ID: 31678415
[TBL] [Abstract][Full Text] [Related]
8. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
9. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
11. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
12. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes.
Xing L; Zeng R; Huang K; Xue J; Liu H; Zhao Z; Peng Y; Hu X; Liu C
Front Pharmacol; 2022; 13():907921. PubMed ID: 36249820
[No Abstract] [Full Text] [Related]
13. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
14. An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism.
Gao Y; Shi W; Yao H; Ai Y; Li R; Wang Z; Liu T; Dai W; Xiao X; Zhao J; Niu M; Bai Z
Front Pharmacol; 2021; 12():747010. PubMed ID: 34630116
[TBL] [Abstract][Full Text] [Related]
15. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
[No Abstract] [Full Text] [Related]
17. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.
Chen CH; Hung CH; Hu TH; Wang JH; Lu SN; Su PF; Lee CM
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1984-92.e1. PubMed ID: 26073492
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
[No Abstract] [Full Text] [Related]
20. Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats.
Liu H; Zhang Z; Hu H; Zhang C; Niu M; Li R; Wang J; Bai Z; Xiao X
BMC Complement Altern Med; 2018 Jul; 18(1):212. PubMed ID: 29986685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
